Pediatrics Doctors in Avon, CT Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Meredith Barrows, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 21 B Arts Center Court, Avon, CT 06001 Phone: 860-678-9400    Fax: 860-678-9480

Thomas B Binder, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 21b Arts Center Court, Avon, CT 06001 Phone: 860-673-9400    Fax: 860-678-9480

Dr. Elizabeth Ruel Matern, M.D. PSYCHIATRIST Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Dale Road, Suite 201, Avon, CT 06001 Phone: 860-676-9350    Fax: 860-678-7178

Dr. Cindy Lee St. Onge, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 Dale Rd, Avon, CT 06001 Phone: 860-678-0484    Fax: 860-678-1454

Dr. Kenneth Perks, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 34 Dale Rd, Suite 205, Avon, CT 06001 Phone: 860-676-1111    Fax: 860-676-0134

Steven Jay Brown, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 34 Dale Rd, Avon, CT 06001 Phone: 860-676-1111    Fax: 860-676-0134

Dr. Molly Kruger Naples, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 21b Arts Center Ct, Avon, CT 06001 Phone: 860-248-0000

News Archive

Men who receive brachytherapy more likely to be cancer-free five years later

Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later.

PPD to evaluate FDA's post-market spontaneous adverse event surveillance system

PPD, Inc. today announced it has been awarded a contract by the U.S. Food and Drug Administration (FDA) to evaluate the agency's Center for Drug Evaluation and Research (CDER) post-market spontaneous adverse event surveillance system. The company will conduct a thorough evaluation of the value of the spontaneous adverse event reports to support safety-related regulatory actions and report its findings to the FDA and the public.

Ligand Pharmaceuticals announces launch of redesigned Web site

Ligand Pharmaceuticals Incorporated announces the launch of its completely redesigned Web site: www.ligand.com. The new Web site is designed as a comprehensive resource for investors, prospective corporate partners and the life science community to learn more about Ligand's business model, robust pipeline, high-profile partnerships and innovative technology.

The Black Death still lurks all over the world

Beijing, the capital of the economic giant, China, is in the news currently for a far different reason – two patients have developed pneumonic plague. The patients, who hail from Inner Mongolia's northwestern corner, are being treated at a high-level hospital there, amidst 21 million other people. The health authorities say they have put in place adequate protection and control measures to keep the plague from spreading.

Read more Medical News

› Verified 5 days ago